Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 3721-3740 of 3,895 trials

A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

NCT00203307

Olanzapine (o-lan-zah-peen) is a medication that has been approved by the Food and Drug Administration (FDA) for the treatment of patients with schizophrenia and/ or bipolar disorder. The trade name for this drug is Zyprexa®. Olanzapine has not been approved by the FDA for the prevention of migraine and is experimental for the purposes of this research study. The Jefferson Headache Center at Thomas Jefferson University has developed this clinical study to evaluate the safety and effectiveness of Olanzapine in preventing migraine headaches.

Migraine

Thomas Jefferson University3 participantsStarted May 2004

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura

NCT00449540

Assess safety and efficacy of Transcranial Magnetic Stimulation (TMS) for the treatment of migraine with aura The hypothesis is that TMS treatments delivered to the occipital cortex of the brain can stop or interrupt the spreading cortical brain activity that causes or contributes to the migraine headache. Two TMS treatments at an intensity of \<1 Tesla for \~500 microseconds, approximately 30 seconds apart, may stop the aura and prevent the subsequent headache.

Migraine With Aura

Neuralieve201 participantsStarted Aug 2006

San Francisco, California, United States • Denver, Colorado, United States • Chicago, Illinois, United States +11 more locations

A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura

Rheumatoid Arthritis Trials in Other Cities

A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches

Sternal Wall Pressure in the Cath Lab

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia

A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)

Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia

A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy

DPBRN Persistent Pain and Root Canal Therapy

DPBRN Peri-operative Pain and Root Canal Therapy

Other Conditions in Philadelphia